HopeStage
Back to all studies
CompletedNCT00175357

Medically prescribed heroin with methadone compared with methadone alone for opioid addiction

About this titleRead the official source — NCT00175357
Medication studyAges 25+Canada
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 25 years.

Listed locations
Vancouver and 1 more locationSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMarch 2005
Recruitment status
Completed
Enrollment listed in the registry
192
Sponsor
University of British Columbia
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Canada
Age range
Over 25 Years
Official registry ID
NCT00175357
Official title
Show the full official title

North American Opiate Medication Initiative (NAOMI): Multi-Centre, Randomized Controlled Trial of Heroin-Assisted Therapy for Treatment-Refractory Injection Opiate Users

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Vancouver · Montreal

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of British Columbia, a university.

Did this study involve medication?

Yes. The study involved medication, including Methadone and Diamorphine hydrochloride.

Who was this study for?

Listed age limits: from 25 years.

Want to explore more studies?

Explore studies